WikiMD is the world's largest medical encyclopedia with
13,854 pages, 4,142,505 edits & 40,133,090 views.
ATR kinase inhibitor BAY1895344
An orally available ataxia telangiectasia and Rad3-related (ATR)-specific kinase inhibitor, with potential antineoplastic activity. Upon oral administration, ATR kinase inhibitor BAY1895344 selectively binds to and inhibits the activity of ATR, which prevents ATR-mediated signaling. This inhibits DNA damage checkpoint activation, disrupts DNA damage repair and induces apoptosis in ATR-overexpressing tumor cells. ATR, a serine/threonine protein kinase upregulated in a variety of cancer cell types, plays a key role in DNA repair, cell cycle progression and cell survival.
Learn more about ATR kinase inhibitor BAY1895344
- Dailymed label info
- Scientific articles
- Drug portal ATR kinase inhibitor BAY1895344
- toxicity info on ATR kinase inhibitor BAY1895344
- FDA ATR kinase inhibitor BAY1895344
Latest research - ATR kinase inhibitor BAY1895344
External links
This WikiMD article ATR kinase inhibitor BAY1895344 is a stub. If you are familiar with the topic ATR kinase inhibitor BAY1895344, you can help us. Paid editors welcome!
ATR kinase inhibitor BAY1895344 is part of WikiMD's free ^articles!
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
 Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available |
